IL-2-secreting recombinant bacillus Calmette Guerin can overcome a Type 2 immune response and corticosteroid-induced immunosupression to elicit a Type 1 immune response

International Immunology

Volumn 14, Issue 7, 2002, Pages 793-800

  Young, Sarah L ^a   O'Donnell, Michael A ^b   Buchan, Glenn S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Bacillus Calmette Guerin; Cytokine; Immunotherapy; Th1 Th2; Tuberculosis; Vaccination

Indexed keywords

BCG VACCINE; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT VACCINE; GLUCOCORTICOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; BCG VACCINATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; C3H MOUSE; C57BL MOUSE; CELLULAR IMMUNITY; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; VACCINATION;

ANIMALS; BCG VACCINE; DEXAMETHASONE; GLUCOCORTICOIDS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; TH1 CELLS; TH2 CELLS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0036312592     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Tuberculosis: Commentary on a reemergent killer
2. Spleen cell cytokine secretion in M. bovis BCG-infected mice
3. Immunity to intracellular bacteria
4. Immunity to mycobacteria
5. Delayed-type hypersensitivity: Mycobacterial vaccines and protective immunity
6. A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trials
7. Recombinant Mycobacterium bovis BCG secreting functional IL-2 enhances gamma interferon production by splenocytes
8. IL-2 augments natural killer cell activity
9. Selective activation of resting human γδ T lymphocytes by interleukin 2
10. Early appearing γδ bearing T cells during infection with Calmette Guerin bacillus
11. NK cells and NKT cells in innate defense against viral infections
12. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins
13. The protective immune response to Mycobacterium tuberculosis
14. An essential role for IFN-γ resistance to Mycobacterium tuberculosis
15. An in vivo comparison of bacillus Calmette-Guerin (BCG) and cytokines-secreting BCG vaccines
16. Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2 and IL-18 secreting recombinant BCG
17. Vaccination against tuberculosis: Is BCG more sinned against than sinner?
18. BCG vaccination against tuberculosis: Past disappointments and future hopes
19. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in Northern Malawi
20. Racial differences in susceptibility to infection by Mycobacterium tuberculosis
21. Factors in the resistance of guinea pigs to tuberculosis, with especial regard to inbreeding and heredity
22. Specificity of a protective immune response against Mycobacterium tuberculosis
23. The cytokine response to bacille Calmette Guerin vaccination in South India
24. Effects of stress on the immune system
25. + lymphocytes by inhibiting IL-2 production
26. Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs
27. Immune responsiveness and lymphocyte production in patients with tuberculosis and healthy controls
28. Activation of an IL-4 mRNA producing population of PBMCs after infection with Mycobacterium bovis or vaccination with killed, but not live, BCG
29. T cell subset distribution and B cell hyperactivity in mice expressing interleukin 4 under the control of major histocompatibility complex class I regulatory sequence
30. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
31. Manipulation and potentiation of anti-mycobacterial immunity using recombinant BCG strains that secrete cytokines
32. Regulation of cytokine and cytokine receptor expression by glucocorticoids
33. h2 response in vivo
34. Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells
35. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids
36. Heredity, constitution and tuberculosis, an experimental study
37. The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG
38. Immunisation of BALB/c mice with mIFN-gamma-secreting Mycobacterium bovis BCG provides early protection against Leishmania major infection
39. Antiproliferative effect of IFN-γ in immune regulation
40. A recombinant extracellular domain of the human interleukin-4 receptor inhibits the biological effects of IL-4 on T and B lymphocytes